Eintrag weiter verarbeiten
Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer
Gespeichert in:
| Zeitschriftentitel: | JNCI Journal of the National Cancer Institute |
|---|---|
| Personen und Körperschaften: | |
| In: | JNCI Journal of the National Cancer Institute, 100, 2008, 6, S. 445-446 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Oxford University Press (OUP)
|
| Schlagwörter: |
| author_facet |
Stewart, D. J. Stewart, D. J. |
|---|---|
| author |
Stewart, D. J. |
| spellingShingle |
Stewart, D. J. JNCI Journal of the National Cancer Institute Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer Cancer Research Oncology |
| author_sort |
stewart, d. j. |
| spelling |
Stewart, D. J. 0027-8874 1460-2105 Oxford University Press (OUP) Cancer Research Oncology http://dx.doi.org/10.1093/jnci/djn021 Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer JNCI Journal of the National Cancer Institute |
| doi_str_mv |
10.1093/jnci/djn021 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9qbmNpL2RqbjAyMQ |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9qbmNpL2RqbjAyMQ |
| institution |
DE-Bn3 DE-Brt1 DE-D161 DE-Zwi2 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 |
| imprint |
Oxford University Press (OUP), 2008 |
| imprint_str_mv |
Oxford University Press (OUP), 2008 |
| issn |
0027-8874 1460-2105 |
| issn_str_mv |
0027-8874 1460-2105 |
| language |
English |
| mega_collection |
Oxford University Press (OUP) (CrossRef) |
| match_str |
stewart2008redesignofphaseiicancertrialsusingacontinuousendpointofchangeintumorsizeapplicationtoastudyofsorafenibanderlotinibinnonsmallcelllungcancer |
| publishDateSort |
2008 |
| publisher |
Oxford University Press (OUP) |
| recordtype |
ai |
| record_format |
ai |
| series |
JNCI Journal of the National Cancer Institute |
| source_id |
49 |
| title |
Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| title_unstemmed |
Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| title_full |
Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| title_fullStr |
Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| title_full_unstemmed |
Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| title_short |
Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| title_sort |
re: design of phase ii cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non-small cell lung cancer |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1093/jnci/djn021 |
| publishDate |
2008 |
| physical |
445-446 |
| description |
|
| container_issue |
6 |
| container_start_page |
445 |
| container_title |
JNCI Journal of the National Cancer Institute |
| container_volume |
100 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792321086429331460 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T10:56:26.536Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Re%3A+Design+of+Phase+II+Cancer+Trials+Using+a+Continuous+Endpoint+of+Change+in+Tumor+Size%3A+Application+to+a+Study+of+Sorafenib+and+Erlotinib+in+Non-Small+Cell+Lung+Cancer&rft.date=2008-03-19&genre=article&issn=1460-2105&volume=100&issue=6&spage=445&epage=446&pages=445-446&jtitle=JNCI+Journal+of+the+National+Cancer+Institute&atitle=Re%3A+Design+of+Phase+II+Cancer+Trials+Using+a+Continuous+Endpoint+of+Change+in+Tumor+Size%3A+Application+to+a+Study+of+Sorafenib+and+Erlotinib+in+Non-Small+Cell+Lung+Cancer&aulast=Stewart&aufirst=D.+J.&rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjn021&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792321086429331460 |
| author | Stewart, D. J. |
| author_facet | Stewart, D. J., Stewart, D. J. |
| author_sort | stewart, d. j. |
| container_issue | 6 |
| container_start_page | 445 |
| container_title | JNCI Journal of the National Cancer Institute |
| container_volume | 100 |
| description | |
| doi_str_mv | 10.1093/jnci/djn021 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9qbmNpL2RqbjAyMQ |
| imprint | Oxford University Press (OUP), 2008 |
| imprint_str_mv | Oxford University Press (OUP), 2008 |
| institution | DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275 |
| issn | 0027-8874, 1460-2105 |
| issn_str_mv | 0027-8874, 1460-2105 |
| language | English |
| last_indexed | 2024-03-01T10:56:26.536Z |
| match_str | stewart2008redesignofphaseiicancertrialsusingacontinuousendpointofchangeintumorsizeapplicationtoastudyofsorafenibanderlotinibinnonsmallcelllungcancer |
| mega_collection | Oxford University Press (OUP) (CrossRef) |
| physical | 445-446 |
| publishDate | 2008 |
| publishDateSort | 2008 |
| publisher | Oxford University Press (OUP) |
| record_format | ai |
| recordtype | ai |
| series | JNCI Journal of the National Cancer Institute |
| source_id | 49 |
| spelling | Stewart, D. J. 0027-8874 1460-2105 Oxford University Press (OUP) Cancer Research Oncology http://dx.doi.org/10.1093/jnci/djn021 Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer JNCI Journal of the National Cancer Institute |
| spellingShingle | Stewart, D. J., JNCI Journal of the National Cancer Institute, Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer, Cancer Research, Oncology |
| title | Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| title_full | Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| title_fullStr | Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| title_full_unstemmed | Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| title_short | Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| title_sort | re: design of phase ii cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non-small cell lung cancer |
| title_unstemmed | Re: Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1093/jnci/djn021 |